cyclopentenone has been researched along with 15-deoxyprostaglandin j2 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Brossart, P; Denzlinger, C; Grünebach, F; Lauber, K; Nencioni, A; Van Parijs, L; Wesselborg, S | 1 |
| Chen, HZ; Rovin, BH; Zhang, X | 1 |
| Araki, E; Brownlee, M; Kiritoshi, S; Kukidome, D; Matsumura, T; Matsuo, T; Nishikawa, T; Pestell, RG; Sakai, M; Senokuchi, T; Sonoda, K; Yano, M | 1 |
| Emi, M; Maeyama, K | 1 |
| Ciucci, A; Gianferretti, P; Guyot, T; Piva, R; Roberts, SM; Santoro, MG; Snape, TJ | 1 |
| Avellano, MI; Cañada, FJ; Carrasco, MJ; Gayarre, J; Pérez-Sala, D; Sánchez-Gómez, FJ | 1 |
| Jang, SK; Kim, JH; Kim, WJ | 1 |
| Di Maio, R; Graham, SH; Gronenborn, AM; Kodali, RB; Koharudin, LM; Liu, H | 1 |
| Agúndez, JA; Ayuso, P; Dorado, CG; Pajares, MA; Pérez-Sala, D; Sánchez-Gómez, FJ | 1 |
| Ahmad, M; Graham, SH; Hickey, RW; Li, W; Liu, H; Miller, TM; Pascoe, JL; Poloyac, SM; Rose, ME | 1 |
| Bretscher, P; Carreira, EM; Egger, J; Fischer, S; Freigang, S; Kopf, M | 1 |
| Chistyakov, DV; Chistyakov, VV; Goriainov, SV; Grabeklis, S; Reiser, G; Sergeeva, MG | 1 |
| Broz, P; Carreira, EM; Ebner, C; Feng, Q; Kopf, M; Muri, J; Shamshiev, A; Tortola, L; Wolleb, H | 1 |
| Cheung, KH; Huang, SY; Iyaswamy, A; Krishnamoorthi, S; Li, M; Liu, J; Lu, JH; Song, JX; Sreenivasmurthy, SG; Su, CF; Tan, JQ; Tong, BC; Wang, ZY; Wu, JX; Yang, CB; Zhu, Z | 1 |
14 other study(ies) available for cyclopentenone and 15-deoxyprostaglandin j2
| Article | Year |
|---|---|
Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
Topics: Apoptosis; Cyclopentanes; Down-Regulation; Growth Inhibitors; Humans; Intracellular Membranes; Jurkat Cells; Lymphocyte Activation; Membrane Potentials; Mitochondria; Oxidative Stress; Permeability; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Rosiglitazone; Signal Transduction; T-Lymphocyte Subsets; Thiazolidinediones; Transcription Factors | 2003 |
Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin.
Topics: Animals; Anthozoa; Cyclopentanes; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Regulation; Genes, Reporter; Genetic Variation; Humans; Kidney; Luciferases; Prostaglandin D2; Prostaglandins; Transfection | 2003 |
15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB.
Topics: Animals; Base Sequence; Cell Division; Cell Line; Cyclopentanes; DNA; Electrophoretic Mobility Shift Assay; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lipoproteins, LDL; Luciferases; Macrophages; Male; Mice; Mice, Inbred C3H; NF-kappa B; Promoter Regions, Genetic; Prostaglandin D2; Thymidine; Transcriptional Activation; Transfection | 2004 |
The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
Topics: Animals; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Division; Cyclopentanes; Drug Interactions; Enzyme Inhibitors; Histamine; Leukemia, Basophilic, Acute; Prostaglandin D2; Prostaglandins; Rats; Tumor Cells, Cultured | 2004 |
Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acid; Breast Neoplasms; Caspases; Cyclopentanes; Down-Regulation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; I-kappa B Kinase; Inhibitor of Apoptosis Proteins; NF-kappa B; Prostaglandin D2; Receptors, Estrogen; Tumor Cells, Cultured | 2006 |
Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro.
Topics: Anti-Inflammatory Agents; Biotinylation; Cyclopentanes; Cystine; Dose-Response Relationship, Drug; Gastrointestinal Agents; Gene Expression Regulation; Glutathione; Humans; In Vitro Techniques; Oxygen; Prostaglandin D2; Prostaglandins; Protein Binding; Recombinant Proteins; Transcription Factors | 2007 |
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.
Topics: Anti-Inflammatory Agents; Arachidonic Acid; Arsenites; Chromans; Cyclopentanes; Cytoplasmic Granules; Dinoprostone; Emetine; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4A; Gene Expression Regulation; HeLa Cells; Humans; Hypoglycemic Agents; Inflammation; Poly(A)-Binding Proteins; PPAR gamma; Prostaglandin D2; Prostaglandins A; Protein Biosynthesis; Protein Synthesis Inhibitors; Rosiglitazone; Signal Transduction; Sodium Compounds; T-Cell Intracellular Antigen-1; Thiazolidinediones; TNF Receptor-Associated Factor 2; Troglitazone; Tumor Necrosis Factor-alpha | 2007 |
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.
Topics: Animals; Cyclopentanes; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mutation; Parkinson Disease; Prostaglandin D2; Protein Denaturation; Rats; Rats, Sprague-Dawley; Ubiquitin Thiolesterase | 2010 |
Modulation of GSTP1-1 oligomerization by electrophilic inflammatory mediators and reactive drugs.
Topics: Cell-Free System; Cyclopentanes; Glutathione S-Transferase pi; Humans; Hydrocarbons, Aromatic; Inflammation; Inflammation Mediators; Jurkat Cells; Metabolic Detoxication, Phase II; Molecular Targeted Therapy; Oxidation-Reduction; Prostaglandin D2; Protein Multimerization; Reactive Oxygen Species; Signal Transduction | 2013 |
Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites.
Topics: Animals; Apoptosis; Carbazoles; Cells, Cultured; Cerebral Cortex; Cyclopentanes; Dose-Response Relationship, Drug; Embryo, Mammalian; Hypoxia; Intramolecular Oxidoreductases; Lipocalins; Mice; Mice, Knockout; Neurons; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Sulfonamides | 2013 |
Total Synthesis of Prostaglandin 15d-PGJ(2) and Investigation of its Effect on the Secretion of IL-6 and IL-12.
Topics: Cyclopentanes; Cytokines; Interleukin-12; Interleukin-6; Molecular Structure; Prostaglandin D2; Structure-Activity Relationship | 2015 |
Astrocytes synthesize primary and cyclopentenone prostaglandins that are negative regulators of their proliferation.
Topics: Animals; Astrocytes; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Cyclopentanes; Lipopolysaccharides; PPAR gamma; Prostaglandin D2; Prostaglandins; Prostaglandins A; Rats, Wistar; Tandem Mass Spectrometry | 2018 |
Cyclopentenone Prostaglandins and Structurally Related Oxidized Lipid Species Instigate and Share Distinct Pro- and Anti-inflammatory Pathways.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Caspase 8; CD40 Antigens; Cell Death; Cell Differentiation; Cyclopentanes; Dendritic Cells; Inflammasomes; Inflammation; Interleukins; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mitochondria; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; NF-kappa B; Oxidation-Reduction; Phenotype; Prostaglandin D2; Prostaglandins; Signal Transduction; Th1 Cells; Toll-Like Receptors; Transcription, Genetic; Up-Regulation | 2020 |
TFEB, a master regulator of autophagy and biogenesis, unexpectedly promotes apoptosis in response to the cyclopentenone prostaglandin 15d-PGJ2.
Topics: Apoptosis; Autophagy; Cyclopentanes; Prostaglandin D2; Prostaglandins; Reactive Oxygen Species | 2022 |